1 Introduction to Research & Analysis Reports
1.1 Chronic Obstructive Pulmonary Disease Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Overall Market Size
2.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size: 2022 VS 2029
2.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Obstructive Pulmonary Disease Treatment Drug Players in Global Market
3.2 Top Global Chronic Obstructive Pulmonary Disease Treatment Drug Companies Ranked by Revenue
3.3 Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Chronic Obstructive Pulmonary Disease Treatment Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chronic Obstructive Pulmonary Disease Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disease Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Chronic Obstructive Pulmonary Disease Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disease Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Markets, 2022 & 2029
4.1.2 Bronchodilators
4.1.3 PDE-4 Inhibitors
4.1.4 Steroids
4.1.5 Others
4.2 By Type – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue & Forecasts
4.2.1 By Type – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2023
4.2.2 By Type – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2024-2029
4.2.3 By Type – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue & Forecasts
5.2.1 By Application – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2023
5.2.2 By Application – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2024-2029
5.2.3 By Application – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2022 & 2029
6.2 By Region – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue & Forecasts
6.2.1 By Region – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2023
6.2.2 By Region – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2024-2029
6.2.3 By Region – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2029
6.3.2 US Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.3.3 Canada Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.3.4 Mexico Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2029
6.4.2 Germany Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.4.3 France Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.4.4 U.K. Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.4.5 Italy Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.4.6 Russia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.4.7 Nordic Countries Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.4.8 Benelux Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2029
6.5.2 China Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.5.3 Japan Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.5.4 South Korea Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.5.5 Southeast Asia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.5.6 India Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2029
6.6.2 Brazil Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.6.3 Argentina Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2029
6.7.2 Turkey Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.7.3 Israel Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
6.7.5 UAE Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, 2018-2029
7 Chronic Obstructive Pulmonary Disease Treatment Drug Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.1.4 GSK Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.2.4 Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.3.4 Merck Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.4.4 Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.5.4 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.6.4 AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.7.4 Roche Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.8.4 Teva Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Vectura
7.9.1 Vectura Company Summary
7.9.2 Vectura Business Overview
7.9.3 Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.9.4 Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.9.5 Vectura Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.10.4 Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Mylan
7.11.1 Mylan Company Summary
7.11.2 Mylan Business Overview
7.11.3 Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.11.4 Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.11.5 Mylan Key News & Latest Developments
7.12 Allergan
7.12.1 Allergan Company Summary
7.12.2 Allergan Business Overview
7.12.3 Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.12.4 Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.12.5 Allergan Key News & Latest Developments
7.13 Cipla
7.13.1 Cipla Company Summary
7.13.2 Cipla Business Overview
7.13.3 Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.13.4 Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.13.5 Cipla Key News & Latest Developments
7.14 Akorn
7.14.1 Akorn Company Summary
7.14.2 Akorn Business Overview
7.14.3 Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Major Product Offerings
7.14.4 Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global Market (2018-2023)
7.14.5 Akorn Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Chronic Obstructive Pulmonary Disease Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Chronic Obstructive Pulmonary Disease Treatment Drug Market Drivers in Global Market
Table 3. Chronic Obstructive Pulmonary Disease Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Chronic Obstructive Pulmonary Disease Treatment Drug in Global Market
Table 5. Top Chronic Obstructive Pulmonary Disease Treatment Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chronic Obstructive Pulmonary Disease Treatment Drug Product Type
Table 9. List of Global Tier 1 Chronic Obstructive Pulmonary Disease Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disease Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 30. GSK Company Summary
Table 31. GSK Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 32. GSK Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 36. Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 40. Merck Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Abbott Company Summary
Table 43. Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 44. Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Key News & Latest Developments
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 48. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 52. AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 56. Roche Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Teva Company Summary
Table 59. Teva Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 60. Teva Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Key News & Latest Developments
Table 62. Vectura Company Summary
Table 63. Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 64. Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Vectura Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 68. Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Mylan Company Summary
Table 71. Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 72. Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Mylan Key News & Latest Developments
Table 74. Allergan Company Summary
Table 75. Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 76. Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Allergan Key News & Latest Developments
Table 78. Cipla Company Summary
Table 79. Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 80. Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Cipla Key News & Latest Developments
Table 82. Akorn Company Summary
Table 83. Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Product Offerings
Table 84. Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Akorn Key News & Latest Developments
List of Figures
Figure 1. Chronic Obstructive Pulmonary Disease Treatment Drug Segment by Type in 2022
Figure 2. Chronic Obstructive Pulmonary Disease Treatment Drug Segment by Application in 2022
Figure 3. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in 2022
Figure 8. By Type - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 16. US Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 20. Germany Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 28. China Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 41. GSK Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Roche Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
